Wird geladen...
Randomized study of the effect of gadopiclenol, a new gadolinium‐based contrast agent, on the QTc interval in healthy subjects
AIMS: We investigated the effect of gadopiclenol, a new gadolinium‐based contrast agent, on the QTc interval at clinical and supraclinical dose, considering the relative hyperosmolarity of this product. METHODS: This was a single centre, randomized, double‐blind, placebo‐ and positive‐controlled, 4‐...
Gespeichert in:
| Veröffentlicht in: | Br J Clin Pharmacol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7576613/ https://ncbi.nlm.nih.gov/pubmed/32302009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14309 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|